Regulation of sphingomyelin metabolism

Pharmacological Reports

Volumn 68, Issue 3, 2016, Pages 570-581

  Kamil, Bienias ^a   Anna, Fiedorowicz ^a,b   Anna, Sadowska ^a   Sławomir, Prokopiuk ^a   Halina, Car ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Acid sphingomyelinase; Neutral sphingomyelinase; Sphingomyelin; Sphingomyelin synthases

Indexed keywords

ALKALINE SPHINGOMYELINASE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN SYNTHASE 1; SPHINGOMYELIN SYNTHASE 2; SPHINGOMYELIN SYNTHASE RELATED PROTEIN; SYNTHETASE; UNCLASSIFIED DRUG; PHOSPHATIDYLCHOLINE-CERAMIDE PHOSPHOCHOLINE TRANSFERASE; PHOSPHOTRANSFERASE;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; DEPRESSION; HUMAN; LIPID METABOLISM; NIEMANN PICK DISEASE; NONHUMAN; PARKINSON DISEASE; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; ANIMAL; ENZYMOLOGY; METABOLISM; REPERFUSION INJURY;

ALZHEIMER DISEASE; ANIMALS; DEPRESSION; HUMANS; NIEMANN-PICK DISEASES; PARKINSON DISEASE; REPERFUSION INJURY; SCHIZOPHRENIA; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 84959512133     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.12.008     Document Type: Review

References (197)

1. A. Filippov, G. Orädd, and G. Lindblom Sphingomyelin structure influences the lateral diffusion and raft formation in lipid bilayers Biophys J 90 6 2006 2086 2092
2. W. Stillwell An introduction to biological membranes from bilayers to rafts 1st ed. 2013 Elsevier [chapter 5]
3. A.A. Karlsson, P. Michélsen, and G. Odham Molecular species of sphingomyelin: Determination by high-performance liquid chromatography/mass spectrometry with electrospray and high-performance liquid chromatography/tandem mass spectrometry with atmospheric pressure chemical ionization J Mass Spectrom 33 12 1998 1192 1198
4. N.E. Furland, S.R. Zanetti, G.M. Oresti, E.N. Maldonado, and M.I. Aveldanõ Ceramides and sphingomyelins with high proportions of very long-chain polyunsaturated fatty acids in mammalian germ cells J Biol Chem 282 25 2007 18141 18150
5. B. Ramstedt, and J.P. Slotte Membrane properties of sphingomyelins FEBS Lett 531 1 2002 33 37
6. M. Kuikka, B. Ramstedt, H. Ohvo-Rekilä, J. Tuuf, and J.P. Slotte Membrane properties of D-erythro-N-acyl sphingomyelins and their corresponding dihydro species Biophys J 80 5 2001 2327 2337
7. C.C. Kan, Z.S. Ruan, and R. Bittman Interaction of cholesterol with sphingomyelin in bilayer membranes: Evidence that the hydroxy group of sphingomyelin does not modulate the rate of cholesterol exchange between vesicles Biochemistry 30 31 1991 7759 7766
8. D. Needham, and R.S. Nunn Elastic deformation and failure of lipid bilayer membranes containing cholesterol Biophys J 58 4 1990 997 1009
9. R.J. Schroeder, S.N. Ahmed, Y. Zhu, E. London, and D.A. Brown Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains J Biol Chem 273 2 1998 1150 1157
10. A. Prinetti, V. Chigorno, S. Prioni, N. Loberto, N. Marano, G. Tettamanti, and et al. Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro J Biol Chem 276 24 2001 21136 21145
11. M. Koval, and R.E. Pagano Intracellular transport and metabolism of sphingomyelin Biochim Biophys Acta 1082 2 1991 113 125
12. B. Ramstedt, and J.P. Slotte Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: A comparative study of the effect of the chain length Biophys J 76 2 1999 908 915
13. R. Bittman, C.R. Kasireddy, P. Mattjus, and J.P. Slotte Interaction of cholesterol with sphingomyelin in monolayers and vesicles Biochemistry 33 39 1994 11776 11781
14. S. Jaikishan, A. Björkbom, and J.P. Slotte Sphingomyelin analogs with branched N-acyl chains: The position of branching dramatically affects acyl chain order and sterol interactions in bilayer membranes Biochim Biophys Acta 1798 10 2010 1987 1994
15. B. Ramstedt, and J.P. Slotte Comparison of the biophysical properties of racemic and d-erythro-N-acyl sphingomyelins Biophys J 77 3 1999 1498 1506
16. L. Bini, S. Pacini, S. Liberatori, S. Valensin, M. Pellegrini, R. Raggiaschi, and et al. Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering Biochem J 369 2 2003 301 309
17. D.A. Brown, and E. London Structure and function of sphingolipid-and cholesterol-rich membrane rafts J Biol Chem 275 23 2000 17221 17224
18. A.H Merrill Jr., G. van Echten, E. Wang, and K. Sandhoff Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ J Biol Chem 268 36 1993 27299 27306
19. A. Schweizer, H. Clausen, G. van Meer, and H.P. Hauri Localization of O-glycan initiation, sphingomyelin synthesis, and glucosylceramide synthesis in Vero cells with respect to the endoplasmic reticulum-Golgi intermediate compartment J Biol Chem 269 6 1994 4035 4041
20. K. Funato, and H. Riezman Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast J Cell Biol 155 6 2001 949 959
21. K. Hanada Intracellular trafficking of ceramide by ceramide transfer protein Proc Jpn Acad Ser B Phys Biol Sci 86 4 2010 426 437
22. X. Wang, R.P. Rao, T. Kosakowska-Cholody, M.A. Masood, E. Southon, H. Zhang, and et al. Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice J Cell Biol 184 1 2009 143 158
23. A.H. Futerman, B. Stieger, A.L. Hubbard, and R.E. Pagano Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus J Biol Chem 265 15 1990 8650 8657
24. G. van Meer, and J.C. Holthuis Sphingolipid transport in eukaryotic cells Biochim Biophys Acta 1486 1 2000 145 170
25. E.H. Schuchman, M. Suchi, T. Takahashi, K. Sandhoff, and R.J. Desnick Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs J Biol Chem 266 13 1991 8531 8539
26. B.X. Wu, C.J. Clarke, and Y.A. Hannun Mammalian neutral sphingomyelinases: Regulation and roles in cell signaling responses Neuromolecular Med 12 4 2010 320 330
27. D. Milhas, C.J. Clarke, and Y.A. Hannun Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids FEBS Lett 584 9 2010 1887 1894
28. T. Ding, I. Kabir, Y. Li, C. Lou, A. Yazdanyar, J. Xu, and et al. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity J Lipid Res 56 3 2015 537 545
29. C. Yeang, T. Ding, W.J. Chirico, and X.C. Jiang Subcellular targeting domains of sphingomyelin synthase 1 and 2 Nutr Metab (Lond) 8 2011 89
30. C. Yeang, S. Varshney, R. Wang, Y. Zhang, D. Ye, and X.C. Jiang The domain responsible for sphingomyelin synthase (SMS) activity Biochim Biophys Acta 1781 10 2008 610 617
31. Z. Li, T.K. Hailemariam, H. Zhou, Y. Li, D.C. Duckworth, D.A. Peake, and et al. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization Biochim Biophys Acta 1771 9 2007 1186 1194
32. F.G. Tafesse, K. Huitema, M. Hermansson, S. van der Poel, J. van den Dikkenberg, A. Uphoff, and et al. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells J Biol Chem 282 24 2007 17537 17547
33. O.Y. Sudarkina, I.B. Filippenkov, I.B. Brodsky, S.A. Limborska, and L.V. Dergunova Comparative analysis of sphingomyelin synthase 1 gene expression at the transcriptional and translational levels in human tissues Mol Cell Biochem 406 1-2 2015 91 99
34. K. Huitema, J. van den Dikkenberg, J.F. Brouwers, and J.C. Holthuis Identification of a family of animal sphingomyelin synthases EMBO J 23 1 2004 33 44
35. F.G. Tafesse, P. Ternes, and J.C. Holthuis The multigenic sphingomyelin synthase family J Biol Chem 281 40 2006 29421 29425
36. U.V. Wesley, J.F. Hatcher, and R.J. Dempsey Sphingomyelin synthase 1 regulates neuro-2a cell proliferation and cell cycle progression through modulation of p27 expression and Akt signaling Mol Neurobiol 51 3 2015 1530 1541
37. M. Taniguchi, and T. Okazaki The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders Biochim Biophys Acta 1841 5 2014 692 703
38. E. Lafont, D. Milhas, S. Carpentier, V. Garcia, Z.X. Jin, H. Umehara, and et al. Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death Cell Death Differ 17 4 2010 642 654
39. L. Riboni, P. Viani, R. Bassi, P. Giussani, and G. Tettamanti Basic fibroblast growth factor-induced proliferation of primary astrocytes. Evidence for the involvement of sphingomyelin biosynthesis J Biol Chem 276 16 2001 12797 12804
40. C. Luberto, and Y.A. Hannun Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J Biol Chem 273 23 1998 14550 14559
41. Z. Cai, A. Bettaieb, N.E. Mahdani, L.G. Legrès, R. Stancou, J. Masliah, and et al. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity J Biol Chem 272 11 1997 6918 6926
42. Y. Taguchi, T. Kondo, M. Watanabe, M. Miyaji, H. Umehara, Y. Kozutsumi, and et al. Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase Blood 104 10 2004 3285 3293
43. L. Dong, K. Watanabe, M. Itoh, C.R. Huan, X.P. Tong, T. Nakamura, and et al. CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice Int Immunol 24 5 2012 327 337
44. F.M. Goñi, and A. Alonso Structure and functional properties of diacylglycerols in membranes Prog Lipid Res 38 1 1999 1 48
45. C. Evangelisti, R. Bortul, F. Falà, G. Tabellini, K. Goto, and A.M. Martelli Nuclear diacylglycerol kinases: Emerging downstream regulators in cell signaling networks Histol Histopathol 22 5 2007 573 579
46. A. Momchilova, and T. Markovska Phosphatidylethanolamine and phosphatidylcholine are sources of diacylglycerol in ras-transformed NIH 3T3 fibroblasts Int J Biochem Cell Biol 31 2 1999 311 318
47. M. Tani, and O. Kuge Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail, which is involved in its localization in plasma membranes Biochem Biophys Res Commun 381 3 2009 328 332
48. T.K. Hailemariam, C. Huan, J. Liu, Z. Li, C. Roman, M. Kalbfeisch, and et al. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation Arterioscler Thromb Vasc Biol 28 8 2008 1519 1526
49. P. Ternes, J.F. Brouwers, J. van den Dikkenberg, and J.C. Holthuis Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase J Lipid Res 50 11 2009 2270 2277
50. Y. Kidani, K. Ohshima, H. Sakai, T. Kohno, A. Baba, and M. Hattori Differential localization of sphingomyelin synthase isoforms in neurons regulates sphingomyelin cluster formation Biochem Biophys Res Commun 417 3 2012 1014 1017
51. Y. Zhang, J. Dong, X. Zhu, W. Wang, and Q. Yang The effect of sphingomyelin synthase 2 (SMS2) deficiency on the expression of drug transporters in mouse brain Biochem Pharmacol 82 3 2011 287 294
52. A.M. Vacaru, F.G. Tafesse, P. Ternes, V. Kondylis, M. Hermansson, J.F. Brouwers, and et al. Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER J Cell Biol 185 6 2009 1013 1027
53. S. Marathe, S.L. Schissel, M.J. Yellin, N. Beatini, R. Mintzer, K.J. Williams, and et al. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling J Biol Chem 273 7 1998 4081 4088
54. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene J Biol Chem 271 31 1996 18431 18436
55. K. Ferlinz, R. Hurwitz, H. Moczall, S. Lansmann, E.H. Schuchman, and K. Sandhoff Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis Eur J Biochem 243 1-2 1997 511 517
56. S.L. Schissel, X. Jiang, J. Tweedie-Hardman, T. Jeong, E.H. Camejo, J. Najib, and et al. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development J Biol Chem 273 5 1998 2738 2746
57. 2+-stimulated sphingomyelinase in fetal bovine serum J Biol Chem 264 10 1989 5358 5363
58. T. Levade, R. Salvayre, and L. Douste-Blazy Sphingomyelinases, and Niemann-Pick disease J Clin Chem Clin Biochem 24 4 1986 205 220
59. I. Takahashi, T. Takahashi, T. Abe, W. Watanabe, and G. Takada Distribution of acid sphingomyelinase in human various body fluids Tohoku J Exp Med 192 1 2000 61 66
60. C. Mühle, H.B. Huttner, S. Walter, M. Reichel, F. Canneva, P. Lewczuk, and et al. Characterization of acid sphingomyelinase activity in human cerebrospinal fluid PLOS ONE 8 5 2013 e62912
61. C.G Simon Jr., S. Chatterjee, and A.R. Gear Sphingomyelinase activity in human platelets Thromb Res 90 4 1998 155 161
62. E. Romiti, V. Vasta, E. Meacci, M. Farnararo, T. Linke, K. Ferlinz, and et al. Characterization of sphingomyelinase activity released by thrombin-stimulated platelets Mol Cell Biochem 205 1-2 2000 75 81
63. V. Vasta, E. Meacci, E. Romiti, M. Farnararo, and P. Bruni Sphingomyelinase increases 2-deoxyglucose uptake and glucose metabolism of human platelets Biochem Mol Biol Int 43 1 1997 217 226
64. P. Münzer, O. Borst, B. Walker, E. Schmid, M.A. Feijge, J.M. Cosemans, and et al. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation Arterioscler Thromb Vasc Biol 34 1 2014 61 71
65. K. Kitatani, T. Oka, T. Murata, M. Hayama, S. Akiba, and T. Sato Acceleration by ceramide of calcium-dependent translocation of phospholipase A2 from cytosol to membranes in platelets Arch Biochem Biophys 382 2 2000 296 302
66. 2+-dependent neutral sphingomyelinase Proc Natl Acad Sci USA 97 11 2000 5895 5900
67. S. Tomiuk, K. Hofmann, M. Nix, M. Zumbansen, and W. Stoffel Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling? Proc Natl Acad Sci USA 95 7 1998 3638 3643
68. M. Tani, and Y.A. Hannun Neutral sphingomyelinase 2 is palmitoylated on multiple cysteine residues. Role of palmitoylation in subcellular localization J Biol Chem 282 13 2007 10047 10056
69. N.A. Crivello, I.H. Rosenberg, G.E. Dallal, D. Bielinski, and J.A. Joseph Age-related changes in neutral sphingomyelin-specific phospholipase C activity in striatum, hippocampus, and frontal cortex: Implication for sensitivity to stress and inflammation Neurochem Int 47 8 2005 573 579
70. W. Stoffel, B. Jenke, B. Blöck, M. Zumbansen, and J. Koebke Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development Proc Natl Acad Sci USA 102 12 2005 4554 4559
71. D. Wheeler, E. Knapp, V.V. Bandaru, Y. Wang, D. Knorr, C. Poirier, and et al. Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors J Neurochem 109 5 2009 1237 1249
72. S.K. Kim, K.H. Ahn, J.E. Ji, J.M. Choi, H.J. Jeon, S.Y. Jung, and et al. Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium Cell Signal 22 5 2010 865 870
73. T. Zheng, W. Li, J. Wang, B.T. Altura, and B.M. Altura Sphingomyelinase ceramide analogs induce contraction and rises in [Ca(2+)](i) in canine cerebral vascular muscle Am J Physiol Heart Circ Physiol 278 5 2000 H1421 H1428
74. R. Bautista-Pérez, L. del Valle-Mondragón, A. Cano-Martínez, O. Pérez-Méndez, B. Escalante, and M. Franco Involvement of neutral sphingomyelinase in the angiotensin II signaling pathway Am J Physiol Renal Physiol 308 10 2015 F1178 F1187
75. K. Mogami, H. Kishi, and S. Kobayashi Sphingomyelinase causes endothelium-dependent vasorelaxation through endothelial nitric oxide production without cytosolic Ca(2+) elevation FEBS Lett 579 2 2005 393 397
76. N. Mueller, E. Avota, L. Collenburg, H. Grassmé, and S. Schneider-Schaulies Neutral sphingomyelinase in physiological and measles virus induced T cell suppression PLoS Pathog 10 12 2014 e1004574
77. Z. Khavandgar, and M. Murshed Sphingolipid metabolism and its role in the skeletal tissues Cell Mol Life Sci 72 5 2015 959 969
78. I. Aubin, C.P. Adams, S. Opsahl, D. Septier, C.E. Bishop, N. Auge, and et al. A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse Nat Genet 37 8 2005 803 805
79. W. Stoffel, B. Jenke, B. Holz, E. Binczek, R.H. Günter, J. Knifka, and et al. Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression Am J Pathol 171 1 2007 153 161
80. S. Tomiuk, M. Zumbansen, and W. Stoffel Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase J Biol Chem 275 8 2000 5710 5717
81. Y. Mizutani, K. Tamiya-Koizumi, N. Nakamura, M. Kobayashi, Y. Hirabayashi, and S. Yoshida Nuclear localization of neutral sphingomyelinase 1: Biochemical and immunocytochemical analyses J Cell Sci 114 Pt 20 2001 3727 3736
82. H. Sawai, N. Domae, N. Nagan, and Y.A. Hannun Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C J Biol Chem 274 53 1999 38131 38139
83. M. Zumbansen, and W. Stoffel Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease Mol Cell Biol 22 11 2002 3633 3638
84. L. Tonnetti, M.C. Verí, E. Bonvini, and L. D'Adamio A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction J Exp Med 189 10 1999 1581 1589
85. 2+-dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis J Biol Chem 283 44 2008 29971 29982
86. T. Yabu, H. Shiba, Y. Shibasaki, T. Nakanishi, S. Imamura, K. Touhata, and et al. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling Cell Death Differ 22 2 2015 258 273
87. B.B. Guo, S.A. Bellingham, and A.F. Hill The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes J Biol Chem 290 6 2015 3455 3467
88. O. Krut, K. Wiegmann, H. Kashkar, B. Yazdanpanah, and M. Krönke Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein J Biol Chem 281 19 2006 13784 13793
89. C.A. Corcoran, Q. He, S. Ponnusamy, B. Ogretmen, Y. Huang, and M.S. Sheikh Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies Mol Cancer Res 6 5 2008 795 807
90. J.S. Moylan, J.D. Smith, E.M. Wolf Horrell, J.B. McLean, G.M. Deevska, M.R. Bonnell, and et al. Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle Redox Biol 2 2014 910 920
91. B.X. Wu, V. Rajagopalan, P.L. Roddy, C.J. Clarke, and Y.A. Hannun Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5 J Biol Chem 285 23 2010 17993 18002
92. V. Rajagopalan, D. Canals, C. Luberto, J. Snider, C. Voelkel-Johnson, L.M. Obeid, and et al. Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization Biochim Biophys Acta 1850 4 2015 628 639
93. H. Birbes, C. Luberto, Y.T. Hsu, S. El Bawab, Y.A. Hannun, and L.M. Obeid A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria Biochem J 386 Pt 3 2005 445 451
94. D.W. Petcoff, W.L. Holland, and B.J. Stith Lipid levels in sperm, eggs, and during fertilization in Xenopus laevis J Lipid Res 49 11 2008 2365 2378
95. N.E. Furland, G.M. Oresti, S.S. Antollini, A. Venturino, E.N. Maldonado, and M.I. Aveldanõ Very long-chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and ceramides in the head of mammalian spermatozoa J Biol Chem 282 25 2007 18151 18161
96. R.D. Duan, T. Bergman, N. Xu, J. Wu, Y. Cheng, J. Duan, and et al. Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family J Biol Chem 278 40 2003 38528 38536
97. R.D. Duan, and A. Nilsson Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity Hepatology 26 4 1997 823 830
98. L. Nyberg, A. Nilsson, P. Lundgren, and R.D. Duan Localization and capacity of sphingomyelin digestion in the rat intestinal tract J Nutr Biochem 8 3 1997 112 118
99. M. Kubota, K. Narita, T. Nakagomi, A. Tamura, H. Shimasaki, N. Ueta, and et al. Sphingomyelin changes in rat cerebral cortex during focal ischemia Neurol Res 18 4 1996 337 341
100. M. Nakane, M. Kubota, T. Nakagomi, A. Tamura, H. Hisaki, H. Shimasaki, and et al. Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus Neurosci Lett 296 2-3 2000 89 92
101. H.P. Tian, T.Z. Qiu, J. Zhao, L.X. Li, and J. Guo Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia Brain Inj 23 13-14 2009 1073 1080
102. S. Soeda, Y. Tsuji, T. Ochiai, K. Mishima, K. Iwasaki, M. Fujiwara, and et al. Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress Neurochem Int 45 5 2004 619 626
103. B. Liu, D.F. Hassler, G.K. Smith, K. Weaver, and Y.A. Hannun Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain J Biol Chem 273 51 1998 34472 34479
104. S. Yoshimura, Y. Banno, S. Nakashima, K. Takenaka, H. Sakai, Y. Nishimura, and et al. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation J Biol Chem 273 12 1998 6921 6927
105. S. Yoshimura, Y. Banno, S. Nakashima, K. Hayashi, H. Yamakawa, M. Sawada, and et al. Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death J Neurochem 73 2 1999 675 683
106. K. Bernardo, O. Krut, K. Wiegmann, D. Kreder, M. Micheli, R. Schäfer, and et al. Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain J Biol Chem 275 11 2000 7641 7647
107. L. Gu, B. Huang, W. Shen, L. Gao, Z. Ding, H. Wu, and et al. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi J Neuroinflammation 10 2013 109
108. R. Ohtani, H. Tomimoto, T. Kondo, H. Wakita, I. Akiguchi, H. Shibasaki, and et al. Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia Brain Res 1023 1 2004 31 40
109. T. Yamashima, A. Mathivanan, M.Y. Dazortsava, S. Sakai, S. Kurimoto, H. Zhu, and et al. Calpain-mediated Hsp70.1 cleavage in monkey CA1 after ischemia induces similar 'lysosomal vesiculosis' to Alzheimer neurons J Alzheimers Dis Parkinsonism 4 2014 139
110. Z.F. Yu, M. Nikolova-Karakashian, D. Zhou, G. Cheng, E.H. Schuchman, and M.P. Mattson Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis J Mol Neurosci 15 2 2000 85 97
111. J. Yu, S.A. Novgorodov, D. Chudakova, H. Zhu, A. Bielawska, J. Bielawski, and et al. JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction J Biol Chem 282 35 2007 25940 25949
112. J. Jin, Q. Hou, T.D. Mullen, Y.H. Zeidan, J. Bielawski, J.M. Kraveka, and et al. Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells J Biol Chem 283 39 2008 26509 26517
113. S.M. Lam, Y. Wang, X. Duan, M.R. Wenk, R.N. Kalaria, C.P. Chen, and et al. Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia Neurobiol Aging 35 10 2014 2369 2381
114. R.B. Chan, T.G. Oliveira, E.P. Cortes, L.S. Honig, K.E. Duff, S.A. Small, and et al. Comparative lipidomic analysis of mouse and human brain with Alzheimer disease J Biol Chem 287 4 2012 2678 2688
115. O. Ben-David, Y. Pewzner-Jung, O. Brenner, E.L. Laviad, A. Kogot-Levin, I. Weissberg, and et al. Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels J Biol Chem 286 34 2011 30022 30033
116. S. Adam-Klages, D. Adam, K. Wiegmann, S. Struve, W. Kolanus, J. Schneider-Mergener, and et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase Cell 86 6 1996 937 947
117. S. Philipp, M. Puchert, S. Adam-Klages, V. Tchikov, S. Winoto-Morbach, S. Mathieu, and et al. The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase Proc Natl Acad Sci USA 107 3 2010 1112 1117
118. S.N. Lavrentiadou, C. Chan, T. Kawcak, T. Ravid, A. Tsaba, A. van der Vliet, and et al. Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione Am J Respir Cell Mol Biol 25 6 2001 676 684
119. K. Yamagata, S. Ichinose, C. Tagawa, and M. Tagami Vitamin E regulates SMase activity, GSH levels, and inhibits neuronal death in stroke-prone spontaneously hypertensive rats during hypoxia and reoxygenation J Exp Stroke Transl Med 2 2 2009 41 48
120. J.S. Won, and I. Singh Sphingolipid signaling and redox regulation Free Radic Biol Med 40 11 2006 1875 1888
121. X. Li, E. Gulbins, and Y. Zhang Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase Cell Physiol Biochem 30 4 2012 815 826
122. W. Wei, C. Du, J. Lv, G. Zhao, Z. Li, Z. Wu, and et al. Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation J Immunol 190 1 2013 138 146
123. V.G. Dmitrieva, E.V. Torshina, V.V. Yuzhakov, O.V. Povarova, V.I. Skvortsova, S.A. Limborska, and et al. Expression of sphingomyelin synthase 1 gene in rat brain focal ischemia Brain Res 1188 2008 222 227
124. M. Morishima-Kawashima, and Y. Ihara Alzheimer's disease: Beta-amyloid protein and tau J Neurosci Res 70 2002 392 401
125. M. Orešič, T. Hyötylaïnen, S.K. Herukka, M. Sysi-Aho, I. Mattila, T. Seppänan-Laakso, and et al. Metabolome in progression to Alzheimer's disease Transl Psychiatry 1 2011 e57
126. M.M. Mielke, V.V. Bandaru, N.J. Haughey, P.V. Rabins, C.G. Lyketsos, and M.C. Carlson Serum sphingomyelins and ceramides are early predictors of memory impairment Neurobiol Aging 31 1 2010 17 24
127. M.M. Mielke, V.V. Bandaru, N.J. Haughey, J. Xia, L.P. Fried, S. Yasar, and et al. Serum ceramides increase the risk of Alzheimer disease: The Women's Health and Aging Study II Neurology 79 7 2012 633 641
128. M. Kosicek, S. Kirsch, R. Bene, Z. Trkanjec, M. Titlic, L. Bindila, and et al. Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients-a pilot study Anal Bioanal Chem 398 7-8 2010 2929 2937
129. M. Kosicek, H. Zetterberg, N. Andreasen, J. Peter-Katalinic, and S. Hecimovic Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease Neurosci Lett 516 2 2012 302 305
130. M.M. Mielke, N.J. Haughey, V.V. Bandaru, H. Zetterberg, K. Blennow, U. Andreasson, and et al. Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease Neurobiol Aging 35 11 2014 2486 2494
131. C.G. Gottfries, B. Jungbjer, I. Karlsson, and L. Svennerholm Reductions in membrane proteins and lipids in basal ganglia of classic Alzheimer disease patients Alzheimer Dis Assoc Disord 10 2 1996 77 81
132. M. Söderberg, C. Edlund, I. Alafuzoff, K. Kristensson, and G. Dallner Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type J Neurochem 59 5 1992 1646 1653
133. X. He, Y. Huang, B. Li, C.X. Gong, and E.H. Schuchman Deregulation of sphingolipid metabolism in Alzheimer's disease Neurobiol Aging 31 3 2010 398 408
134. E. Gulbins Regulation of death receptor signaling and apoptosis by ceramide Pharmacol Res 47 2003 393 399
135. M. Panchal, M. Gaudin, A.N. Lazar, E. Salvati, I. Rivals, S. Ayciriex, and et al. Ceramides and sphingomyelinases in senile plaques Neurobiol Dis 65 2014 193 201
136. R. González-Domínguez, T. Garciá-Barrera, J. Vitorica, and J.L. Gómez-Ariza Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease Biochim Biophys Acta 1842 12 Pt A 2014 2395 2402
137. Y. Tajima, M. Ishikawa, K. Maekawa, M. Murayama, Y. Senoo, T. Nishimaki-Mogami, and et al. Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease Lipids Health Dis 12 2013 68
138. J.M. Cordy, N.M. Hooper, and A.J. Turner The involvement of lipid rafts in Alzheimer's disease Mol Membr Biol 23 1 2006 111 122
139. C.L. Schengrund Lipid rafts: Keys to neurodegeneration Brain Res Bull 82 1-2 2010 7 17
140. N. Fabelo, V. Martín, R. Marín, D. Moreno, I. Ferrer, and M. Diáz Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions Neurobiol Aging 35 8 2014 1801 1812
141. M. Diáz, N. Fabelo, V. Martín, I. Ferrer, T. Gómez, and R. Marín Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer's disease J Alzheimers Dis 43 4 2015 1185 1198
142. A.B. Clement, G. Gimpl, and C. Behl Oxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor protein Free Radic Biol Med 48 9 2010 1236 1241
143. K. Ayasolla, M. Khan, A.K. Singh, and I. Singh Inflammatory mediator and beta-amyloid (25e35)-induced ceramide generation and iNOS expression are inhibited by vitamin E Free Radic Biol Med 37 3 2004 325 338
144. M.O. Grimm, H.S. Grimm, A.J. Pätzold, E.G. Zinser, R. Halonen, M. Duering, and et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin Nat Cell Biol 7 11 2005 1118 1123
145. M.B. Dinkins, S. Dasgupta, G. Wang, G. Zhu, and E. Bieberich Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease Neurobiol Aging 35 8 2014 1792 1800
146. K. Yuyama, H. Sun, S. Mitsutake, and Y. Igarashi Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia J Biol Chem 287 14 2012 10977 10989
147. J.K. Lee, H.K. Jin, M.H. Park, B.R. Kim, P.H. Lee, H. Nakauchi, and et al. Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease J Exp Med 211 8 2014 1551 1570
148. V.V. Bandaru, J. Troncoso, D. Wheeler, O. Pletnikova, J. Wang, K. Conant, and et al. ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain Neurobiol Aging 30 4 2009 591 599
149. M. Maes, R. Smith, A. Christophe, E. Vandoolaeghe, A. Van Gastel, H. Neels, and et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers Acta Psychiatr Scand 95 3 1997 212 221
150. D.L. Musselman, D.L. Evans, and C.B. Nemeroff The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment Arch Gen Psychiatry 55 7 1998 580 592
151. G. Cizza, P. Ravn, G.P. Chrousos, and P.W. Gold Depression: A major, unrecognized risk factor for osteoporosis? Trends Endocrinol Metab 12 5 2001 198 203
152. A. Demirkan, A. Isaacs, P. Ugocsai, G. Liebisch, M. Struchalin, I. Rudan, and et al. Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study J Psychiatr Res 47 3 2013 357 362
153. J. Kornhuber, A. Medlin, S. Bleich, V. Jendrossek, A.W. Henkel, J. Wiltfang, and et al. High activity of acid sphingomyelinase in major depression J Neural Transm (Vienna) 112 11 2005 1583 1590
154. S.D. Geddes, S. Assadzada, A. Sokolovski, R. Bergeron, S. Haj-Dahmane, and J.C. Beíque Time-dependent modulation of glutamate synapses onto 5-HT neurons by antidepressant treatment Neuropharmacology 95 2015 130 143
155. A. Meneses Tianeptine: 5-HT uptake sites and 5-HT(1-7) receptors modulate memory formation in an autoshaping Pavlovian/instrumental task Neurosci Biobehav Rev 26 3 2002 309 319
156. B. Sjögren, and P. Svenningsson Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells Acta Physiol (Oxf) 190 1 2007 47 53
157. R. Weng, S. Shen, L. Yang, M. Li, Y. Tian, Y. Bai, and et al. Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry Rapid Commun Mass Spectrom 29 16 2015 1491 1500
158. J. Kornhuber, P. Tripal, M. Reichel, C. Mühle, C. Rhein, M. Muehlbacher, and et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A novel pharmacological group of drugs with broad clinical applications Cell Physiol Biochem 26 1 2010 9 20
159. E. Gulbins, M. Palmada, M. Reichel, A. Lüth, C. Böhmer, D. Amato, and et al. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs Nat Med 19 7 2013 934 938
160. M.S. Keshavan, A.G. Mallinger, J.W. Pettegrew, and C. Dippold Erythrocyte membrane phospholipids in psychotic patients Psychiatry Res 49 1 1993 89 95
161. A.M. Ponizovsky, I. Modai, Y. Nechamkin, G. Barshtein, M.S. Ritsner, S. Yedgar, and et al. Phospholipid patterns of erythrocytes in schizophrenia: Relationships to symptomatology Schizophr Res 52 1-2 2001 121 126
162. A. Schmitt, K. Wilczek, K. Blennow, A. Maras, A. Jatzko, G. Petroianu, and et al. Altered thalamic membrane phospholipids in schizophrenia: A postmortem study Biol Psychiatry 56 1 2004 41 45
163. J.O. Colón-Saéz, and Yakel J.L. The α7 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane J Physiol 589 Pt 13 2011 3163 3174
164. J.L. Eriksen, Z. Wszolek, and L. Petrucelli Molecular pathogenesis of Parkinson disease Arch Neurol 62 3 2005 353 357
165. M. Xilouri, T. Vogiatzi, K. Vekrellis, and L. Stefanis Alpha-synuclein degradation by autophagic pathways: A potential key to Parkinson's disease pathogenesis Autophagy 4 7 2008 917 919
166. E. Dagan, I. Schlesinger, M. Ayoub, A. Mory, M. Nassar, A. Kurolap, and et al. The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews Parkinsonism Relat Disord 21 9 2015 1067 1071
167. J.N. Foo, H. Liany, J.X. Bei, X.Q. Yu, J. Liu, W.L. Au, and et al. Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease Neurobiol Aging 34 12 2013 2890.e13-5
168. Z. Gan-Or, L.J. Ozelius, A. Bar-Shira, R. Saunders-Pullman, A. Mirelman, R. Kornreich, and et al. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease Neurology 80 17 2013 1606 1610
169. A.K. Das, R. Pandit, and S. Maiti Effect of amyloids on the vesicular machinery: Implications for somatic neurotransmission Philos Trans R Soc Lond B Biol Sci 370 1672 2015
170. 13C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein α-Synuclein J Mol Biol 425 16 2013 2973 2987
171. E. Sidransky, M.A. Nalls, J.O. Aasly, J. Aharon-Peretz, G. Annesi, E.R. Barbosa, and et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease N Engl J Med 361 17 2009 1651 1661
172. M.E. Gegg, L. Sweet, B.H. Wang, L.S. Shihabuddin, S.P. Sardi, and A.H. Schapira No evidence for substrate accumulation in Parkinson brains with GBA mutations Mov Disord 30 8 2015 Jul 1085 1089
173. N. Fabelo, V. Martín, G. Santpere, R. Marín, L. Torrent, I. Ferrer, and et al. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease Mol Med 17 9-10 2011 1107 1118
174. S.K. Abbott, H. Li, S.S. Munõz, B. Knoch, M. Batterham, K.E. Murphy, and et al. Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease Mov Disord 29 4 2014 518 526
175. Q. Wang, Y. Liu, and J. Zhou Neuroinflammation in Parkinson's disease and its potential as therapeutic target Transl Neurodegener 4 2015 19
176. S. Hunot, B. Brugg, D. Ricard, P.P. Michel, M.P. Muriel, M. Ruberg, and et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease Proc Natl Acad Sci USA 94 14 1997 7531 7536
177. X. He, F. Chen, S. Gatt, and E.H. Schuchman An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease Anal Biochem 293 2 2001 204 211
178. J. Lozano, A. Morales, A. Cremesti, Z. Fuks, J.L. Tilly, E. Schuchman, and et al. Disease versus acid sphingomyelinase deficiency Cell Death Differ 8 1 2001 100 103
179. O. Levran, R.J. Desnick, and E.H. Schuchman A frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients Proc Natl Acad Sci USA 88 9 1991 3748 3752
180. C.M. Simonaro, R.J. Desnick, M.M. McGovern, M.P. Wasserstein, and E.H. Schuchman The demographics and distribution of type B Niemann-Pick disease: Novel mutations lead to new genotype/phenotype correlations Am J Hum Genet 71 6 2002 1413 1419
181. B. Tóth, M. Erdos, A. Székely, L. Ritli, P. Bagossi, J. Sümegi, and et al. Molecular genetic characterization of novel sphingomyelin phosphodiesterase 1 mutations causing Niemann-Pick disease JIMD Rep 3 2012 125 129
182. H. Zhang, Y. Wang, Z. Gong, X. Li, W. Qiu, L. Han, and et al. Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann-Pick disease Orphanet J Rare Dis 8 2013 15
183. P. Irun, M. Mallén, C. Dominguez, V. Rodriguez-Sureda, L.A. Alvarez-Sala, N. Arslan, and et al. Identification of seven novel SMPD1 mutations causing Niemann-Pick disease types A and B Clin Genet 84 4 2013 356 361
184. M.D. Manshadi, B. Kamalidehghan, F. Keshavarzi, O. Aryani, S. Dadgar, A. Arastehkani, and et al. Four novel p.N385K, p.V36A, c.1033-1034insT and c.1417-1418delCT mutations in the sphingomyelin phosphodiesterase 1 (SMPD1) gene in patients with types A and B Niemann-Pick disease (NPD) Int J Mol Sci 16 4 2015 6668 6676
185. H.J. Kwon, L. Abi-Mosleh, M.L. Wang, J. Deisenhofer, J.L. Goldstein, M.S. Brown, and et al. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol Cell 137 7 2009 1213 1224
186. M.T. Vanier, and G. Millat Structure and function of the NPC2 protein Biochim Biophys Acta 1685 1-3 2004 14 21
187. G.H. Thomas, C.M. Tuck-Muller, C.S. Miller, and L.W. Reynolds Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media J Inherit Metab Dis 12 2 1989 139 151
188. P.G. Pentchev, M.E. Comly, H.S. Kruth, M.T. Vanier, D.A. Wenger, S. Patel, and et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients Proc Natl Acad Sci USA 82 23 1985 8247 8251
189. M.M. McGovern, A. Aron, S.E. Brodie, R.J. Desnick, and M.P. Wasserstein Natural history of type A Niemann-Pick disease; possible endpoints for therapeutic trials Neurology 66 2 2006 228 232
190. M.P. Wasserstein, R.J. Desnick, E.H. Schuchman, S. Hossain, S. Wallenstein, C. Lamm, and et al. The natural history of type B Niemann-Pick disease: Results from a 10-year longitudinal study Pediatrics 114 6 2004 e672 e677
191. M.P. Wasserstein, A.E. Larkin, R.B. Glass, E.H. Schuchman, R.J. Desnick, and M.M. McGovern Growth restriction in children with type B Niemann-Pick disease J Pediatr 142 4 2003 424 428
192. S. Marathe, S.R. Miranda, C. Devlin, A. Johns, G. Kuriakose, K.J. Williams, and et al. Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: Relationship between brain intra-lysosomal enzyme activity and central nervous system function Hum Mol Genet 9 13 2000 1967 1976
193. E. Gabandé-Rodríguez, P. Boya, V. Labrador, C.G. Dotti, and M.D. Ledesma High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A Cell Death Differ 21 6 2014 864 875
194. S.L. Macauley, R.L. Sidman, E.H. Schuchman, T. Taksir, and G.R. Stewart Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration Exp Neurol 214 2 2008 181 192
195. S.R. Miranda, X. He, C.M. Simonaro, S. Gatt, A. Dagan, R.J. Desnick, and et al. Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology FASEB J 14 13 2000 1988 1995
196. J.C. Dodge, J. Clarke, C.M. Treleaven, T.V. Taksir, D.A. Griffiths, W. Yang, and et al. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease Exp Neurol 215 2 2009 349 357
197. J.M. Murray, A.M. Thompson, A. Vitsky, M. Hawes, W.L. Chuang, J. Pacheco, and et al. Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: The utility of animal models of disease in the toxicological evaluation of potential therapeutics Mol Genet Metab 114 2 2015 217 225